Fusion of KIF5B and RET transforming gene in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing
- Young Seok Ju1,
- Won-Chul Lee1,
- Jong-Yeon Shin1,
- Seungbok Lee1,
- Thomas Bleazard1,
- Jae-Kyung Won2,
- Young Tae Kim3,
- Jong-Il Kim4,
- Jin-Hyoung Kang5 and
- Jeong-Sun Seo1,6
- 1 Genomic Medicine Institute Seoul National University;
- 2 Molecular Pathology, Seoul National University Cancer Hospital;
- 3 Department of Thoracic and Cardiovascular Surgery, Clinical Research Institute, Seoul National Univ.;
- 4 Seoul National University;
- 5 Department of internal medicine, Seoul St. Mary's Hospital, The Catholic University, Seoul, Korea
- ↵* Corresponding author; email: jeongsun{at}snu.ac.kr
Abstract
Identification of the molecular events which drive cancer transformation is essential to the development of targeted agents which improve the clinical outcome of lung cancer. Many studies have reported genomic driver mutations in non-small cell lung cancers (NSCLC) over the past decade, however, the molecular pathogenesis of more than 40% of NSCLC is still unknown. To identify new molecular targets in NSCLC, we performed the combined analysis of massively parallel whole-genome and transcriptome sequencing for cancer and paired normal tissue of a 33-year-old lung adenocarcinoma patient, who is a never-smoker and has no familial cancer history. The cancer showed no known driver mutation in EGFR or KRAS and no EML4-ALK fusion. Here we report a novel fusion gene between KIF5B and RET proto-oncogene caused by a pericentric inversion of 10p11.22-q11.21. This fusion gene overexpresses chimeric RET receptor tyrosine kinase, which could spontaneously induce cellular transformation. We identified the KIF5B-RET fusion in two more cases out of twenty primary lung adenocarcinomas in the replication study. Our data demonstrate that a subset of NSCLC could be caused by a fusion of KIF5B and RET, and suggest the chimeric oncogene as a promising molecular target for the personalized diagnosis and treatment of lung cancer.
- Received October 19, 2011.
- Accepted December 19, 2011.
- Copyright © 2011, Cold Spring Harbor Laboratory Press
This manuscript is Open Access.
